Skip to content

Avanos Medical AVNS Total Equity

Total Equity at other companies

Cardinal Health logo
Cardinal HealthCAH
-$2.83B+3.9%
Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$653.89M-18.1%
Medtronic logo
MedtronicMDT
$49.46B+3.0%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$312.42M+33.3%
IAR
Integra LifeSciencesIART
$1.04B-31.6%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B-1.2%
Enterprise value$1.24B+3.0%
P/S1.6×-0.1×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's total equity?
Avanos Medical (AVNS) reported total equity of $782.1M in Q1 2026.
How has Avanos Medical's total equity changed year-over-year?
Avanos Medical's total equity decreased by 6.8% year-over-year, from $839.4M to $782.1M.
What is the long-term trend for Avanos Medical's total equity?
Over 5 years (2020 to 2025), Avanos Medical's total equity has grown at a -9.2% compound annual growth rate (CAGR), from $1.26B to $778.2M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.